Pieris Pharmaceuticals
(NASDAQ) PIRS
Pieris Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$53.00K
Net Income (TTM)
$35.07M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PIRS News
PIRS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pieris Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Stephen S. Yoder
Website
www.pieris.comHeadquarters
Boston, MA 02109, US
PIRS Financials
Key Financial Metrics (TTM)
Gross Margin
-13%
Operating Margin
-238%
Net Income Margin
662%
Return on Equity
-69%
Return on Capital
22%
Return on Assets
-52%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$10.84M
Capital Expenditure
$0.00
Free Cash Flow
$10.84M
Cash & ST Invst.
$83.60M
Total Debt
$0.00
Pieris Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
46
N/A
Net Income
$11.35M
-293.0%
EBITDA
$9.84M
-213.7%
Quarterly Fundamentals
Net Cash
$63.57M
+228.3%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-52.39%
N/A
Return on Invested Capital
22.28%
N/A
Free Cash Flow
$7.88M
-5495.9%
Operating Cash Flow
$7.88M
-5495.9%